Simple blood test may spot hidden liver damage in obesity
NCT ID NCT07663188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a common blood test called FIB-4 can accurately predict liver fibrosis (scarring) in people with obesity. Researchers will compare FIB-4 results with liver stiffness measurements from a specialized scan (FibroScan) in 400 obese patients. If the blood test works well, it could help identify those who need further liver evaluation without unnecessary procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If FIB-4 proves accurate, it could become a standard first-step test to identify liver fibrosis in obese patients without needing immediate specialized scans.
- What could go wrong
- This is an observational study, not a treatment trial. The FIB-4 test may not be accurate enough to replace current methods, and results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Hidden liver risk in type 1 diabetes: a new study investigates
- Heart scans could flag Who's at risk after liver shunt
- Could a common b vitamin tame fatty liver?
- Could a daily dose of citrus fiber tame fatty liver inflammation?
- Could a diabetes drug also heal fatty liver disease?
- HIV and fatty liver: scientists hunt for hidden clues in the blood